Connecticut § 21a-70g Investigational drug, biological product or device for patients with terminal illnesses. Liability of manufacturer.

Connecticut Statutes

§ 21a-70g — Investigational drug, biological product or device for patients with terminal illnesses. Liability of manufacturer.

Connecticut § 21a-70g

Title 21aConsumer Protection

Ch. 417General Provisions. Pure Food and Drugs

This text of Connecticut § 21a-70g (Investigational drug, biological product or device for patients with terminal illnesses. Liability of manufacturer.) is published on Counsel Stack Legal Research, covering Connecticut primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook

Conn. Gen. Stat. § 21a-70g (2026).

Text

(a)A manufacturer of an investigational drug, biological product or device, as defined in section 20-14q, may make available the manufacturer's investigational drug, biological product or device to a patient who is eligible under subsection (b) of section 20-14q and may (1) provide the investigational drug, biological product or device to such patient without receiving compensation, or (2) require such patient to pay the costs of, or associated with, the manufacture of the investigational drug, biological product or device.

(b)Nothing in this section shall create a cause of action against a manufacturer of an investigational drug, biological product or device that makes available such investigational drug, biological product or device to an eligible patient for any harm done to such pati

Free access — add to your briefcase to read the full text and ask questions with AI

(a) A manufacturer of an investigational drug, biological product or device, as defined in section 20-14q, may make available the manufacturer's investigational drug, biological product or device to a patient who is eligible under subsection (b) of section 20-14q and may (1) provide the investigational drug, biological product or device to such patient without receiving compensation, or (2) require such patient to pay the costs of, or associated with, the manufacture of the investigational drug, biological product or device. (b) Nothing in this section shall create a cause of action against a manufacturer of an investigational drug, biological product or device that makes available such investigational drug, biological product or device to an eligible patient for any harm done to such patient resulting from the investigational drug, biological product or device.